Join today and have your say! It’s FREE!

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Post by GoldenInvestoron Feb 06, 2020 12:52pm
94 Views
Post# 30652726

BIOTECH & BIOPHARMA discussed on CNBC

BIOTECH & BIOPHARMA discussed on CNBC-discussing consistent long term growth prospects of industry, discussing big drug co.'s

- one is marketing drugs, & another growth area is one that discovers drugs & innovates

- now, it's a GUD thing to have both at Knight.

GUD + GBT + $250 MILLION+, of future acquisitions or drug purchases 

Bullboard Posts